Taken together, the aforementioned data support a major role for MEK5/ERK5 signaling in chemoresistance, particularly suggesting that ERK5 inhibition increases 5-FU apoptotic activity in colon cancer cells. The gene discussed is MAP2K5; the disease is colonic neoplasm.